For psoriatic patients who develop bullous pemphigoid, a rare yet serious complication, prompt initiation of combined glucocorticoid and methotrexate provides rapid disease control and sustained remission. This regimen serves as an effective steroid-sparing strategy, though long-term monitoring remains essential to manage recurrence risks during steroid taper.
Ma et al. (Sun,) studied this question.